Related Experiment Videos
Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and
Vidar Beisvag1, Per Kristian Lehre, Herman Midelfart
1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway. vidar.beisvag@utnu.no
European Journal of Heart Failure
|June 7, 2006
Summary
Gene expression profiling identified distinct molecular markers and biological processes for coronary artery disease and dilated cardiomyopathy in end-stage heart failure. This approach aids in understanding heart failure aetiologies and finding diagnostic markers.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Genomics
Background:
- End-stage heart failure presents diverse aetiologies.
- Identifying specific molecular pathways is crucial for understanding disease progression.
Purpose of the Study:
- To identify aetiology-specific biological processes in end-stage heart failure.
- To discover potential molecular markers for coronary artery disease (CAD) and dilated cardiomyopathy (DCM).
Main Methods:
- Gene expression profiling of myocardial samples from CAD and DCM patients versus non-failing hearts.
- Utilized custom arrays of 7000 human genes.
- Applied functional annotation (Gene Ontology) and classification analysis.
Main Results:
- Identified differential expression of 153 genes in CAD and 147 genes in DCM compared to controls.
- Observed aetiology-specific patterns related to catabolism and protein kinase activity regulation.
- Developed gene expression classifiers, with MMP3, FBLN1, ABCB1, and IRX5 being key markers.
Conclusions:
- Combining gene expression data, functional annotation, and classification is effective for identifying disease-specific markers.
- This strategy can differentiate between end-stage CAD and DCM.
- Potential molecular markers were identified for CAD and DCM.
